Patents Examined by Jennifer Ann Benavides
  • Patent number: 11639393
    Abstract: The present disclosure provides anti-CCR8 antibodies, including compositions and methods of using such antibodies.
    Type: Grant
    Filed: July 27, 2022
    Date of Patent: May 2, 2023
    Inventors: Andrew J. McCluskey, Amanda M. Schmidt Paustian, Jane Seagal, Julie L. Wilsbacher
  • Patent number: 11613584
    Abstract: Disclosed is an antibody that specifically binds CD70, or an antigen binding portion thereof. A nucleic acid molecule encoding the antibody or antigen binding portion thereof, an expression vector and a host cell comprising the nucleic acid molecule, a method for expressing the antibody or antigen binding portion thereof, and a method for treating a disease associated with CD70 signaling using the antibody or antigen binding portion thereof are also provided.
    Type: Grant
    Filed: March 3, 2022
    Date of Patent: March 28, 2023
    Assignee: IMMUNEONCO BIOPHARMACEUTICALS (SHANGHAI) INC.
    Inventors: Wenzhi Tian, Song Li, Dianze Chen, Huiqin Guo